<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedBookArticle><BookDocument><PMID Version="1">31305972</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK543978</ArticleId></ArticleIdList><Book><Publisher><PublisherName>Canadian Agency for Drugs and Technologies in Health</PublisherName><PublisherLocation>Ottawa (ON)</PublisherLocation></Publisher><BookTitle book="srcl0577">Clinical Review Report: Efinaconazole (Jublia): (Valeant Canada LP): <b>Indication:</b> For the topical treatment of mild-to-moderate onychomycosis (tinea unguium) of toenails without lunula involvement due to <i>Trichophyton rubrum</i> and <i>Trichophyton mentagrophytes</i> in immunocompetent adult patients</BookTitle><PubDate><Year>2019</Year><Month>06</Month></PubDate><CollectionTitle book="cadthcdrcollect">CADTH Common Drug Reviews</CollectionTitle><Medium>Internet</Medium></Book><Language>eng</Language><PublicationType UI="D016454">Review</PublicationType><Abstract><AbstractText>The objective of this review is to perform a systematic review of the beneficial and harmful effects of efinaconazole for the topical treatment of mild-to-moderate onychomycosis (tinea unguium) of toenails without lunula involvement due to <i>Trichophyton rubrum</i> and <i>Trichophyton mentagrophytes</i> in immunocompetent adult patients.</AbstractText><CopyrightInformation>Copyright Â© 2019 Canadian Agency for Drugs and Technologies in Health.</CopyrightInformation></Abstract><Sections><Section><SectionTitle book="srcl0577" part="clabb">Abbreviations</SectionTitle></Section><Section><SectionTitle book="srcl0577" part="cl1">Executive Summary</SectionTitle></Section><Section><SectionTitle book="srcl0577" part="cl2">Introduction</SectionTitle></Section><Section><SectionTitle book="srcl0577" part="cl3">Objectives and Methods</SectionTitle></Section><Section><SectionTitle book="srcl0577" part="cl4">Results</SectionTitle></Section><Section><SectionTitle book="srcl0577" part="cl5">Discussion</SectionTitle></Section><Section><LocationLabel Type="appendix">Appendix 1</LocationLabel><SectionTitle book="srcl0577" part="cl.app1">Patient Input Summary</SectionTitle></Section><Section><LocationLabel Type="appendix">Appendix 2</LocationLabel><SectionTitle book="srcl0577" part="cl.app2">Literature Search Strategy</SectionTitle></Section><Section><LocationLabel Type="appendix">Appendix 3</LocationLabel><SectionTitle book="srcl0577" part="cl.app3">Excluded Studies</SectionTitle></Section><Section><LocationLabel Type="appendix">Appendix 4</LocationLabel><SectionTitle book="srcl0577" part="cl.app4">Detailed Outcome Data</SectionTitle></Section><Section><LocationLabel Type="appendix">Appendix 5</LocationLabel><SectionTitle book="srcl0577" part="cl.app5">Validity of Outcome Measures</SectionTitle></Section><Section><LocationLabel Type="appendix">Appendix 6</LocationLabel><SectionTitle book="srcl0577" part="cl.app6">Summary of Indirect Comparison</SectionTitle></Section><Section><SectionTitle book="srcl0577" part="cl.rl.r1">References</SectionTitle></Section></Sections></BookDocument><PubmedBookData><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31305972</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle></PubmedArticleSet>
